Latest period
$51.94B
YoY change
+7.7%
5Y CAGR
+9.1%
Peak year (2025)
$53.41B
Latest annual
$53.41B
Total Equity history chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Latest: $53.41B
Total Equity growth chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Latest: +7.7%
Total Equity history table for Thermo Fisher Scientific (TMO) from 1985 to 2025
| 2025 | $53.41B | +7.7% | +$3.82B | ||
| 2024 | $49.58B | +6.1% | +$2.85B | ||
| 2023 | $46.73B | +6.3% | +$2.76B | ||
| 2022 | $43.98B | +7.8% | +$3.19B | ||
| 2021 | $40.79B | +18.2% | +$6.29B | ||
| 2020 | $34.51B | +16.3% | +$4.83B | ||
| 2019 | $29.68B | +7.6% | +$2.09B | ||
| 2018 | $27.59B | +8.6% | +$2.17B | ||
| 2017 | $25.41B | +18.0% | +$3.87B | ||
| 2016 | $21.54B | +0.9% | +$189.10M | ||
| 2015 | $21.35B | +3.9% | +$802.10M | ||
| 2014 | $20.55B | +21.9% | +$3.69B | ||
| 2013 | $16.86B | +9.0% | +$1.39B | ||
| 2012 | $15.46B | +2.8% | +$426.60M | ||
| 2011 | $15.04B | -2.1% | −$322.90M | ||
| 2010 | $15.36B | -0.5% | −$69.90M | ||
| 2009 | $15.43B | +3.4% | +$504.30M | ||
| 2008 | $14.93B | +3.0% | +$438.30M | ||
| 2007 | $14.49B | +4.1% | +$576.47M | ||
| 2006 | $13.91B | +398.0% | +$11.12B | ||
| 2005 | $2.79B | +4.8% | +$127.76M | ||
| 2004 | $2.67B | +11.9% | +$282.74M | ||
| 2003 | $2.38B | +17.2% | +$349.48M | ||
| 2002 | $2.03B | +6.6% | +$125.32M | ||
| 2001 | $1.91B | -24.7% | −$626.00M | ||
| 2000 | $2.53B | +25.8% | +$520.00M | ||
| 1999 | $2.01B | -10.4% | −$234.00M | ||
| 1998 | $2.25B | +12.5% | +$250.00M | ||
| 1997 | $2.00B | +13.9% | +$244.00M | ||
| 1996 | $1.75B | +34.9% | +$454.00M | ||
| 1995 | $1.30B | +31.3% | +$309.70M | ||
| 1994 | $990.30M | +13.4% | +$117.30M | ||
| 1993 | $873.00M | +56.3% | +$314.60M | ||
| 1992 | $558.40M | +14.8% | +$71.90M | ||
| 1991 | $486.50M | +54.0% | +$170.60M | ||
| 1990 | $315.90M | +50.0% | +$105.30M | ||
| 1989 | $210.60M | +16.0% | +$29.10M | ||
| 1988 | $181.50M | +12.2% | +$19.70M | ||
| 1987 | $161.80M | +11.0% | +$16.00M | ||
| 1986 | $145.80M | +43.5% | +$44.20M | ||
| 1985 | $101.60M | — | — |
- 2025$53.41B+7.7%
- 2024$49.58B+6.1%
- 2023$46.73B+6.3%
- 2022$43.98B+7.8%
- 2021$40.79B+18.2%
- 2020$34.51B+16.3%
- 2019$29.68B+7.6%
- 2018$27.59B+8.6%
- 2017$25.41B+18.0%
- 2016$21.54B+0.9%
- 2015$21.35B+3.9%
- 2014$20.55B+21.9%
- 2013$16.86B+9.0%
- 2012$15.46B+2.8%
- 2011$15.04B-2.1%
- 2010$15.36B-0.5%
- 2009$15.43B+3.4%
- 2008$14.93B+3.0%
- 2007$14.49B+4.1%
- 2006$13.91B+398.0%
- 2005$2.79B+4.8%
- 2004$2.67B+11.9%
- 2003$2.38B+17.2%
- 2002$2.03B+6.6%
- 2001$1.91B-24.7%
- 2000$2.53B+25.8%
- 1999$2.01B-10.4%
- 1998$2.25B+12.5%
- 1997$2.00B+13.9%
- 1996$1.75B+34.9%
- 1995$1.30B+31.3%
- 1994$990.30M+13.4%
- 1993$873.00M+56.3%
- 1992$558.40M+14.8%
- 1991$486.50M+54.0%
- 1990$315.90M+50.0%
- 1989$210.60M+16.0%
- 1988$181.50M+12.2%
- 1987$161.80M+11.0%
- 1986$145.80M+43.5%
- 1985$101.60M—
Total Equity values are taken from Thermo Fisher Scientific's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's latest reported total equity is $51.94B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Thermo Fisher Scientific (TMO) reported total equity of $53.41B – grew 7.7% year-over-year.
Through 2020–2025 (5 years), Thermo Fisher Scientific total equity delivered a +9.1% annualised rate; sustaining 14 straight years of year-over-year growth.
2025 marks the peak total equity at $53.41B, with the historical low of $101.60M recorded in 1985.
Thermo Fisher Scientific Total Equity by Year
Thermo Fisher Scientific Total Equity 2025: $53.41B
Thermo Fisher Scientific posted total equity of $53.41B in 2025, grew 7.7% from 2024. This figure represents the highest annual value in the available history.
Thermo Fisher Scientific Total Equity 2024: $49.58B
In 2024, Thermo Fisher Scientific reported total equity of $49.58B, grew 6.1% from 2023.
Thermo Fisher Scientific Total Equity 2023: $46.73B
Thermo Fisher Scientific total equity in 2023 was $46.73B, grew 6.3% from 2022.
Thermo Fisher Scientific Total Equity 2022: $43.98B
2022's total equity for Thermo Fisher Scientific came in at $43.98B, grew 7.8% from 2021.
Thermo Fisher Scientific Total Equity 2021: $40.79B
Thermo Fisher Scientific total equity in 2021 was $40.79B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers by Total Equity
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation